StockData

Jyong Biotech Ltd. (MENS) stock

MENSNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 0/30
$1.86+0.06 (+3.33%)

Close on Nov 18, 2026Market cap $141.41MP/E –Yield –

Jyong Biotech EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2025 it was -$0.06.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$0.06–
FY2024Dec 31, 2024-$0.04–
FY2023Dec 31, 2023-$0.06–

More Jyong Biotech figures

See a number that looks wrong?